l-carnitine fat loss study Systemic regulation of in nutritional metabolism in zebrafish, Danio rerio Effects of l-carnitine supplementation on
Description
De aanbevolen dagelijkse hoeveelheid niet overschrijden
Yagci A, Gurdal C
The role of mitochondrial dysfunction in Alzheimers disease pathogenesis
Silver J, Schwab ME, Popovich PG
Product L-Carnitine Oral Solution 3g/10ml (30%) Pediatric Therapeutic indications Levocarnitine Pediatric 30% Oral Solution is indicated for the treatment of primary and secondary carnitine deficiency in children of under 12 years, infants and newborns
, L- ,
